
Financial Highlights - Second quarter sales reached $454 million[9], while adjusted free cash flow amounted to $36 million[9] - The adjusted EBITDA margin stood at 210%[9], and the adjusted earnings per share was $075[9] - GAAP net income for the quarter was $60 million[10], with diluted earnings per share at $072[10], and cash provided by operating activities was $44 million[10] Q2 2025 Performance vs Q2 2024 - Sales increased from $433 million to $454 million[27] - Gross margin decreased from 305% to 289%[27] - Selling, General & Research (SAR) expenses decreased from $60 million to $57 million[27], representing a decrease from 138% to 125% of sales[27] - Net income increased from $56 million to $60 million[27], with diluted earnings per share increasing from $067 to $072[27], and adjusted earnings per share increasing from $071 to $075[27] Balance Sheet and Capital Allocation - The company has a strong balance sheet with $148 million in trailing twelve months (TTM) adjusted free cash flow[30] - Liquidity stands at $591 million[30], and the net debt to adjusted EBITDA ratio is 12x[30] - $20 million of share repurchases were made in Q2 2025[30], bringing the year-to-date total to $30 million[30], with $100 million remaining under the $150 million program[30] 2025 Outlook - The company anticipates sales between $1685 billion and $1735 billion[32] - The adjusted EBITDA margin is expected to be between 1925% and 200%[32] - Adjusted earnings per share are projected to be between $240 and $260[32]